Skip NavigationSkip to Content

Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials

  1. Author:
    Yang, Q. E.
    Fong, S. E.
    Li, K. G.
    Gonda, M. A.
    Tobin, G. J.
  2. Author Address

    NCI, SAIC Frederick Inc, Lab Cell & Mol Struct, Frederick, MD 21702 USA. Mudanjiang Med Coll, Dept Med, Mudanjiang City, Heilongjiang, Peoples R China. TransMolecular Inc, Birmingham, AL USA. Biol Mimet Inc, Frederick, MD USA Yang, QE, NCI, SAIC Frederick Inc, Lab Pharmacodynam & Toxicol, Dev Therapeut Program, Bldg 439,POB B, Frederick, MD 21702 USA
    1. Year: 2005
    2. Date: JUN
  1. Journal: Medical Science Monitor
    1. 11
    2. 6
    3. Pages: BR154-BR161
  2. Type of Article: Article
  1. Abstract:

    Background: Although ex vivo expansion of bone marrow (BM) cells has been proposed as an effective method for the early recovery from pancytopenia in patients with bone marrow stem cell transplantation (BMT), the expansion potential and the long-term reconstitution capability of such BM cells is still controversial. We. describe here a multiple cytokine medium (MCM) containing major hematopoietic stimulation factors and conditioned medium from PHA-stimulated murine spleen cells that permits the expansion of BM cells with long-term hematopoietic reconstitution capacity.Material/Methods: Male murine BM cells were expanded in MCM for 4 to 14 days and injected into lethally irradiated syngeneic female mice. The mice were maintained for 18 months after transplantation for evaluation of hematopoietic reconstitution.Results: The expanded cells contained pluripotent hematopoietic stem cells and lineage committed progenitors as well as terminally differentiated cells. They permitted full recovery of lethally irradiated mice in both early and late stages in same numbers equivalent to that of unexpanded cells. More than 80% of the progenitor cells were donor originated after 18 months. Expanded cells were able to be transduced with a retroviral vector expressing beta-galactosidase, and continued to express the marker following BMT.Conclusions: With the use of MCM, the quantity of donor cells from BM and other sources might be greatly reduced. Ex vivo expanded BM cells might also facilitate gene manipulation in vitro by retroviral vectors

    See More

External Sources

  1. WOS: 000230108900003

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel